Esomeprazole 40 mg DR tablets,Nexium 40 mg tablets
Sponsors
Bio-innova and Synchron.Co.,Ltd
Conditions
Bioequivalence study
Bioequivalence study
Esomeprazole
Phase 1
A Bioequivalence study of a randomized, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Esomeprazole 40 mg DR tablets relative to Nexium® 40 mg tablets in healthy Thai adult volunteers under fasting condition
Active, not recruitingTCTR20200629001
Start: 2021-02-15Target: 48Updated: 2026-08-03
Single-Dose, Fed Bioequivalence study of Mylan Esomeprazole 40 mg DR tablets; Mylan Laboratories Limited, India relative to Nexium® 40 mg tablets of AstraZeneca in healthy Thai volunteers
Active, not recruitingTCTR20200630001
Start: 2020-10-29Target: 48Updated: 2026-08-03